Animal Hormone Therapy Market Size (2024 - 2029)

The animal hormone therapy market is anticipated to experience notable growth, driven by factors such as the increasing prevalence of hormonal deficiency diseases in animals, rising meat demand, and expanding animal husbandry practices. The market's expansion is supported by the continuous demand for hormones used in therapeutic applications, despite challenges posed by stringent regulations and associated risks. The COVID-19 pandemic initially disrupted the industry but ultimately had a positive impact on the market due to sustained demand for therapeutic hormones. However, the market's growth trajectory may be influenced by regulatory constraints and safety concerns related to hormone use.

Market Size of Animal Hormone Therapy Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Animal Hormone Therapy Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.52 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Animal Hormone Therapy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Animal Hormone Therapy Market Analysis

The animal hormone therapy market is expected to register a CAGR of 5.52% over the forecast period.

With the outbreak of COVID-19, the animal hormone therapy industry has faced both patterns. Initially, when the pandemic struck, with a rise in a sudden demand for meat, eggs, milk, and other animal food products, the industry faced a sudden spike in demand for growth promoters and performance enhancers. Since animal food processing is not such a process where human involvement and proximity are avoided with animals and humans, the units have to shut down amid the threat of spreading COVID-19. Thus, the market faced a demand reduction. However, the animal hormone used for therapeutic purposes for animals remained continuously in demand and supported the industry. Thus, COVID-19 is expected to show a considerable positive impact on the animal hormone therapy market.

The market growth is predominantly characterized by factors such as the growing burden of hormonal deficiency diseases in animals, rising demand for meat, and increasing animal husbandry. The growing burden of diseases in animals drives the market by focusing on hormones used in the treatment of hormonal deficiency diseases, neoplasia treatment, or replacement therapy. According to the BMC study journal published in November 2021, reproductive system tumors occupied the highest share (39.84%), followed by cutaneous tumors (28.05%), digestive tumors (18.70%), and ocular tumors (4.47%). Among the reproductive system tumors, breast tumors are the most common in female pet dogs, especially for Pekingese (11.43%). Similarly, according to the Pathogenesis of Endocrine Disease in Animals Article of April 2020, hyperthyroidism, Type I diabetes, primary hyperparathyroidism, and primary hyperadrenocorticism were the most common diseases in small animals that involved endocrine hypofunction. Animal hormones are used for fattening and production-boosting purposes in the animal food industry. 

In June 2021, the US Department of Agriculture reported a decline in beef production over a year but a strong demand for broilers, turkey, and pork. Moreover, the rate of animal husbandry is increasing all over the world, which largely concerns animal hormone use for the better health of animals. According to the Report of National Agricultural Statistics Services, United States, in April 2021, broiler production in the United States has been increasing over the last five decades. Thus, concerning the above facts, the animal hormone market is expected to witness significant growth over the forecast period owing to the increase in animal breeding and the rise in animal care.

Although animal hormone therapy has wide applications, the risks associated with the use of animal hormones and the stringent regulatory norms associated with their use may hamper the growth of the animal hormone therapy market.

Animal Hormone Therapy Industry Segmentation

Hormones are the chemical messengers secreted in the bloodstream that coordinate with the nervous system and body organs of animals. Hormones are widely used in animals for therapeutic and physiological purposes, like for the treatment of hormonal deficiency diseases and to increase physiological activities that would enhance the production of food, milk, or growth. Animal hormones are also significantly used in hormone replacement therapy, neoplasia treatment, etc. 

The animal hormone therapy market is segmented by application (growth promotors, performance enhancers, and other applications), animals (companion animals and livestock), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Application
Growth Promotors
Performance Enhancers
Other Applications
By Animals
Companion Animals
Livestock
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Animal Hormone Therapy Market Size Summary

The animal hormone therapy market is poised for significant growth, driven by the increasing demand for meat and the rising prevalence of hormonal deficiency diseases in animals. The market experienced initial challenges due to the COVID-19 pandemic, which disrupted operations and led to a temporary decline in demand. However, the continued need for therapeutic hormones and the surge in animal food product consumption helped stabilize and eventually boost the market. The use of hormones for treatment and enhancement purposes in livestock, including cattle, swine, and poultry, is a key factor contributing to market expansion. The growing focus on animal husbandry and the need for improved animal health further support the market's positive trajectory.

North America is expected to lead the market, supported by advanced animal healthcare infrastructure and ongoing research initiatives. The region's robust demand for nutritious animal-derived products and government support for hormone therapy adoption are significant contributors to market growth. Despite the competitive landscape, with major players like Merck & Co. Inc., Boehringer Ingelheim, and Elanco Inc. dominating the market, technological advancements and the increasing burden of animal diseases are likely to attract new entrants. Regulatory challenges and the risks associated with hormone use remain potential hurdles, but the overall outlook for the animal hormone therapy market remains optimistic, with substantial growth anticipated over the forecast period.

Explore More

Animal Hormone Therapy Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Hormonal Deficiency Diseases in Animals

      2. 1.2.2 Rising Demand For Meat

      3. 1.2.3 Increase in Animal Husbandry

    3. 1.3 Market Restraints

      1. 1.3.1 Side Effects Associated With Use of Animal Hormones

      2. 1.3.2 Stringent Government Regulations Associated With Animal Hormones

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Application

      1. 2.1.1 Growth Promotors

      2. 2.1.2 Performance Enhancers

      3. 2.1.3 Other Applications

    2. 2.2 By Animals

      1. 2.2.1 Companion Animals

      2. 2.2.2 Livestock

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Animal Hormone Therapy Market Size FAQs

The Animal Hormone Therapy Market is projected to register a CAGR of 5.52% during the forecast period (2024-2029)

Boehringer Ingelheim , Virbac Group, Elanco Inc., Merck & Co. Inc. and Soparfin SCA (Vetiquinol) are the major companies operating in the Animal Hormone Therapy Market.

Animal Hormone Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)